Twenty-Six weeks ended | | July 30, 2011 | | July 31, 2010 | |
| | | | | |
Cash flows from operating activities: | | | | | |
Net earnings | | $ | 26,311 | | $ | 22,548 | |
Adjustments to reconcile net earnings to net cash provided by continuing operations: | | | | | |
(Income) loss from discontinued operations, net of tax | | (15 | ) | 411 | |
Depreciation and amortization | | 39,654 | | 36,656 | |
Amortization of deferred gain from asset sales | | (6,302 | ) | (6,299 | ) |
Stock compensation expense | | 1,908 | | 1,998 | |
Deferred income taxes | | 4,238 | | 5,600 | |
Net gain from disposition of assets | | (86 | ) | (2,494 | ) |
Loss from asset impairment | | 389 | | 970 | |
Other | | 272 | | 179 | |
Changes in assets and liabilities, net of the effects of acquisitions: | | | | | |
Decrease in accounts receivable, prepaid expenses and other | | 21,816 | | 19,673 | |
(Increase) decrease in merchandise inventories | | (12,917 | ) | 186 | |
Increase (decrease) in accounts payable | | 12,043 | | (6,298 | ) |
Decrease in accrued expenses | | (33,202 | ) | (14,917 | ) |
(Decrease) increase in other long-term liabilities | | (2,831 | ) | 911 | |
Net cash provided by continuing operations | | 51,278 | | 59,124 | |
Net cash used in discontinued operations | | (44 | ) | (1,249 | ) |
Net cash provided by operating activities | | 51,234 | | 57,875 | |
| | | | | |
Cash flows from investing activities: | | | | | |
Capital expenditures | | (30,636 | ) | (27,284 | ) |
Proceeds from dispositions of assets | | 89 | | 4,077 | |
Premiums paid on life insurance policies | | (795 | ) | (500 | ) |
Acquisitions, net of cash acquired | | (42,757 | ) | (144 | ) |
Collateral investment | | (4,763 | ) | 500 | |
Net cash used in continuing operations | | (78,862 | ) | (23,351 | ) |
Net cash provided by discontinued operations | | — | | 569 | |
Net cash used in investing activities | | (78,862 | ) | (22,782 | ) |
| | | | | |
Cash flows from financing activities: | | | | | |
Borrowings under line of credit agreements | | 5,045 | | 16,290 | |
Payments under line of credit agreements | | (5,045 | ) | (16,290 | ) |
Borrowings on trade payable program liability | | 59,097 | | 63,808 | |
Payments on trade payable program liability | | (53,944 | ) | (42,627 | ) |
Payment for finance issuance cost | | (2,441 | ) | — | |
Debt payments | | (539 | ) | (540 | ) |
Dividends paid | | (3,171 | ) | (3,160 | ) |
Other | | 363 | | 463 | |
Net cash (used in) provided by financing activities | | (635 | ) | 17,944 | |
Net (decrease) increase in cash and cash equivalents | | (28,263 | ) | 53,037 | |
Cash and cash equivalents at beginning of period | | 90,240 | | 39,326 | |
Cash and cash equivalents at end of period | | $ | 61,977 | | $ | 92,363 | |
| | | | | |
Supplemental cash flow information: | | | | | |
Cash paid for income taxes | | $ | 629 | | $ | 810 | |
Cash paid for interest | | $ | 11,523 | | $ | 11,452 | |
Accrued purchases of property and equipment | | $ | 1,416 | | $ | 662 | |